Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven

OTCPK:ARLZQ - Post by User

Old API Wind-down Ltd - Ordinary Shares > Aralez Acquire United States and Canadian Right to Zontivity

<< Previous

Bullboard Posts

Next >>

Comment by GoldenDilemmaon Sep 07, 2016 9:22am

98 Views

Post# 25213173

RE:RE:RE:Aralez Acquire United States and Canadian Right to Zontivity

Based on some preliminary DD, the drug was a flop largely due to Merck's lack of dilligence for having a competent sales force behind it. Though, I imagine if it is going to be pushed alongside Yosprala/etc, and ARLZ sales force is active and focused in this respect, it may do better.

I will read more on the science of it.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading